PFIZER Australia in consultation with the Therapeutic Goods Administration (TGA) is recalling for product correction two products: heparin 5000 U/5 mL injection 50 pack (Batch A473, expiry date Feb 2019) and lignocaine 50 mg/5 mL ampoules (Batch A313, expiry date Nov 2017) due to the "potential for incorrect products in packages".
The recall for product correction was initiated after a NSW consumer being treated with Heparin 5000 IU/5 mL injection 50 pack ampoules found the pack instead contained lignocaine 50mg/5mL ampoules.
The consumer had obtained the pack at a NSW community pharmacy.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Aug 17
